Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine
1 other identifier
observational
100,000
1 country
1
Brief Summary
The purpose of this observational study is to understand the changes in the types of respiratory patients hospitalized in China in recent years through a multicenter retrospective clinical study, and at the same time to understand the reasons for hospitalization and the distribution of different tumor types in oncology patients, so as to provide data support and theoretical basis for the future development of China's respiratory department. The main questions it aims to answer are
- 1.the trend of change of respiratory diseases in China in the past 10 years.
- 2.the trend of change in the causes of hospitalization of respiratory tumor patients in China in the past 10 years.
- 3.the trend of the proportion of each tumor in the respiratory department in China over the past 10 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2024
CompletedFirst Submitted
Initial submission to the registry
October 31, 2024
CompletedFirst Posted
Study publicly available on registry
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedNovember 7, 2024
November 1, 2024
1.6 years
October 31, 2024
November 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
proportion
1. to explore the trend of respiratory diseases (COPD, asthma, bronchiectasis, lung infection, lung cancer, etc.) over the past 10 years in China. 2. to explore the trend of the causes of hospitalization of respiratory tumor patients (pulmonary embolism, airway stenosis, post-surgical complications, lung infection, pneumothorax, tuberculosis, etc.) in China over the past 10 years. 3. to explore the trend of the proportion of each tumor in the respiratory department (brain tumor, nasopharyngeal cancer, thyroid cancer, lung cancer, breast cancer, liver cancer, etc.) over the past 10 years in China.
10 years
Eligibility Criteria
A respiratory oncology epidemiology study based on real-world big data from respiratory medicine, with retrospective data collected from respiratory medicine inpatients at a multicenter for nearly 10 years.
You may qualify if:
- Clinical diagnosis of Respiratory diseases Must be an inpatient
You may not qualify if:
- Non-respiratory inpatients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhou Chengzhilead
Study Sites (1)
Chengzhi Zhou
Guangdong, Guangzhou, 510145, China
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Xiaohong Xie
The First Affiliated Hospital of Guangzhou Medical University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
October 31, 2024
First Posted
November 1, 2024
Study Start
September 5, 2024
Primary Completion
April 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
November 7, 2024
Record last verified: 2024-11